Clin Osteol 2021; 26(1): 15-21

Adherence to non-pharmacological procedures in the treatment of postmenopausal osteoporosis: a pilot studyClinical studies

Kuriplachová Gabriela1, Kendrová Demjanovič Lucia2, Lengyelová Andrea1, Cibríková Silvia1, Nechvátal Pavol2, Pavúková Martina1
1 Katedra ošetrovateľstva, Fakulta zdravotníckych odborov Prešovskej univerzity v Prešove
2 Katedra fyzioterapie, Fakulta zdravotníckych odborov Prešovskej univerzity v Prešove

Aim: The aim of this multicenter cross-sectional study was to identify significant differences in adherence to re­commended non-pharmacological procedures in postmenopausal women depending on age, BMI (Body Mass Index) and duration of treatment. Methods: In the year 2018, the study was carried out in three health centers in Slovakia. It was attended by 174 respondents (women) aged 52-75 years (SD ± 6.31). Inclusive criteria for inclusion of respondents in the study were postmenopause and postmenopausal osteoporosis, diagnosed based on BMD (Bone Mineral Density) values. Data were collected by an initial anamnestic interview, which were supplemented by anthropometric measurements. A non-standardized questionnaire with a Likert scale from 1-5 points was used to determine the respondent´s attitudes towards adherence to non-pharmacological procedures. ANOVA test was used for statistical comparison of data. Spearman´s correlation analysis was used to determine significant correlations between variables. Results: The study found weak correlation between BMI and eating habits (r = 0.17; p = 0.02) and weak correlation between age and adequate alcohol consumption (r = 0.20; p = 0.01). The duration of treatment of the disease did not affect adherence to non-pharmacological procedures. Conclusion: In view of the results obtained a deeper examination of the issue with a larger age range of women is required. Focusing on the types of fitness exercises in the treatment of postmenopausal osteoporosis and their protective significance for health could be the subject of further research.

Keywords: fracture risk; non-pharmacological treatment; osteoporosis; prevention; risk factors

Received: February 10, 2021; Accepted: March 26, 2021; Published: June 11, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuriplachová G, Demjanovič Lucia K, Lengyelová A, Cibríková S, Nechvátal P, Pavúková M. Adherence to non-pharmacological procedures in the treatment of postmenopausal osteoporosis: a pilot study. Clinical Osteology. 2021;26(1):15-21.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Jackuliak P. Základné princípy osteoporózy. In: Payer J, Borovský M et al. Osteoporóza pri vybraných ochoreniach. Herba: Bratislava 2014 : 13-41. ISBN 978-80-89631-19-3.
    2. Sotorník I. Osteoporóza -⁠ epidemiologie a patogeneze. Vnitř Lék 2016; 62(Suppl 6): 84-87.
    3. Běhounek J. Přehled nefarmakologické prevence zlomeniny v terénu osteopatií se zaměřením na fyzickou zátěž. Clin Osteol 2019; 24(3): 101-106.
    4. Payer J, Killinger Z, Jackuliak P et al. Postmenopauzálna osteoporóza: štandardný diagnostický a terapeutický postup. Clin Osteol 2018; 23(1): 18-27.
    5. Kolařík D, Halaška M, Feyereisl J. Repetitorium gynekologie. 2. ed. Maxdorf: Praha 2011. ISBN 978-80-7345-267-4.
    6. Nútite R, Brandi ML, Checchia G. Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med 2019; 14(1): 85-102. Dostupné z DOI: <http://doi: 10.1007 / s11739-018-1874-2>. Go to original source...
    7. Killinger Z, Lalciková E, Payer J. Diagnostika osteoporózy. Via Pract 2013; 10(3-4): 92-94.
    8. Kužma M, Jackuliak P, Killinger Z et al. Vyšetrovacie metódy v osteológii. Univerzita Komenského v Bratislave: Bratislava 2018. ISBN 978-80-223-4520-0.
    9. Kanis JA, Cooper C, Rizzoli R et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2019; 30(1): 3-44. Dostupné z DOI: <http://doi:10.1007/s00198-018-4704-5>. Go to original source...
    10. Štěpán J. Osteoporóza u mužů. Čas Lék Čes 2016; 155(7): 340-348.
    11. Špániková B. Sekundárna osteoporóza pri nádorových ochoreniach. Clin Osteol 2018; 23(1): 9-17.
    12. Rosa J. Diagnostika a léčba postmenopauzální osteoporózy. Osteol Bull 2015; 20(4): 150-168.
    13. Sinaki M, Itoj E, Wahner HW et al. Stronger back muscles reduce the incidence of vertebral fractures. A prospective 10 year follow-up of postmenopausal women. Bone 2002; 30(6): 836-841. Dostupmé z DOI: <http://dx.doi.org/10.1016/s8756-3282(02)00739-1>. Go to original source...
    14. Hurley BF, Hanson ED, Sheaff AK. Strength training as a countermeasure to aging muscle and chronic disease. Sports Med 2011; 41(4):289-306. Dostupné z DOI: <http://dx.doi.org/10.2165/11585920-000000000-00000>. Go to original source...
    15. Kanis JA, Johnell O, De Laet C et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004; 35(2): 375-382. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bone.2004.03.024>. Go to original source...
    16. Bužga M, Šmajstrla V, Bortlík L et al. Překvapivě nízka kostní denzita u obézních pacientů podstupujících bariatrický chirurgický výkon. Osteol Bull 2012; 17(2): 43-49.
    17. Tomková S, Vrško M. Osteoporóza u mužov: čo sa zmenilo? Clin Osteol 2019; 24(3): 93-100.
    18. Blažková Š, Vytřísalová M, Štěpán J et al. Secondary prevention of osteoporosis among general practitioners. Osteol Bull 2012; 17(1):32-35. Go to original source...
    19. Křivohlavý J. Kompliance -⁠ dodržování lékařových příkazů pacientem. Prakt Lék 2000; 80(5): 272-275.
    20. Magurová D, Majerníková Ľ. Teoretické východiská edukácie v zdravotníckej praxi. A-print: Lipovce 2016. ISBN 978-80-89721-13-9.

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.